medigraphic.com
Academia Mexicana de Neurología, A.C.

2010, Número 1

<< Anterior Siguiente >>

Rev Mex Neuroci 2010; 11 (1)


Inflamación e infección: su relación con la enfermedad cerebrovascular isquémica

Vera AH, Vera CH, Maragoto RC, Galvizu SR

Idioma: Español
Referencias bibliográficas: 104
Paginas: 52-62
Archivo PDF: 81.61 Kb.


RESUMEN

Se ha valorado en las distintas fases del proceso de la ateroesclerosis, la importancia de la inflamación y se ha relacionado, asimismo, con las infecciones. La asociación de la ateroesclerosis con la enfermedad cerebrovascular isquémica no es discutida. Se revisa la literatura existente en el MEDLINE, con el fin de evaluar la utilidad del conocimiento de algunos elementos que intervienen en la inflamación y su importancia, como factores de riesgo y valor predictivo en esta afección. En este sentido las investigaciones realizadas no permiten asegurar, definitivamente, la asociación con la enfermedad cerebrovascular y su valor predictivo, por lo que es necesario continuar los estudios a fin de dar respuesta a estas interrogantes. En relación a las infecciones nos podemos expresar con igual criterio.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Report of WHO Task-Force on Stroke and other Cerebrovascular Disorders. Stroke 1989; 20(10): 1407-37.

  2. Special Report From the National Institute of Neurological Disorders and Stroke. Stroke 1990; 21(4): 637-76.

  3. Vera CH. La enfermedad cerebrovascular: aspectos clínicos y epidemiológicos. La Habana, Cuba: Tesis de grado para Especialista de Medicina General Integral; 1999.

  4. Gorelick PB, Sacco RL, Smith DB, Alberts M, Mustone AL, Arder D, et al. Prevention of first stroke: a review of guidelines and a multidisciplinary consensus statement from Nacional Stroke Association. JAMA 1999; 281(12): 1112-20.

  5. Vera AH, Vera CH, Maragoto RC. Nuevos factores e riesgo en la enfermedad cerebrovascular isquémica. Rev Mex Neuroci 2005; 6(1): 68-77.

  6. Lindsberg PJ, Grau AJ. Inflammation and infections as risk factors for ischemic stroke. Stroke 2003; 34(10): 2518-32.

  7. Muir KW, Tyrrell P, Sattar N, Warburton E. Inflammation and ischemic stroke. Curr Opin Neurol 2007; 20(3): 334-42.

  8. Goldstein LB, Adms R, Alberts MJ, Appel LJ, Brass LM, Bushnell ChD, et al. AHA/ASA Guideline. Primary Prevention of Ischemic Stroke. Stroke 2006 37(6): 1583-663.

  9. Paganini-Hill A, Lozano E, Fischberg G, Pérez Barreto M, Rajamani K, Ameriso SF, et al. Infection and risk of Ischemic stroke. Differences among stroke subtypes. Stroke 2003; 34(2): 452-7.

  10. Manousakis G, Jensen MB, Sattin JA, Levine RL. The interface between stroke and infectious disease: infectious diseases leading to stroke and infections complicating stroke. Curr Neurol Neuroosci Rep 2009; 9(1): 28-34.

  11. Huang J, Upadhyay UM, Tamargo RJ. Inflammation in stroke and focal cerebral ischemia. Surg Neurol 2006; 66(3): 232-45.

  12. Samson Y, Lapergue B, Hosseini H. Inflammation and ischaemic stroke: current status and future perspectives. Rev Neurol (Paris) 2005; 161(12Pt 1): 1177-82.

  13. Syrjanen J, Valtonen VV, Iivanainen M, Kaste M, Huttunen JK. Preceding infection as an important risk factor for ischaemic brain infarction in young and middle aged patients. Br Med J (Clin Res Ed) 1988; 296(6630): 1156-60.

  14. Grau AJ, Buggle F, Heindl S, Steichen-Wiehn C.Banerjee T, Maiwald M, et al. Recent infection as a risk factor for cerebrovascular ischemia. Stroke 1995; 26(3): 373-9.

  15. Becher H, Grau A, Steindorf K, Buggle F, Hacke W. Previous infection and other risk factors for acute cerebrovascular ischaemia: attributable risks and the characterisation of high risk groups. J Epidemiol Biostat 2000; 5(5): 277-83.

  16. Elkind MS. Why now? Moving from stroke factors to stroke triggers. Curr Opin Neurol 2007; 20(1): 51-7.

  17. Corrado E, Novo S. Role of inflammation and infection in vascular disease. Acta Chir Belg 2005; 105(6): 567-79.

  18. Fan J, Watanabe T. Inflammatory reactions in the pathogenesis of atherosclerosis. J Atheroscler Thromb 2003; 10(2): 63-71.

  19. Mahmoudi M, Curzen N, Gallagher PJ. Atherogenesis: the rol of inflammation and infection. Histopathology 2007; 50(5): 535-46.

  20. Kaperonis EA, Liapis CD, Kakines JD, Dimitroules D, Papavassilion VG. Inflammation and atherosclerosis. Eur J Vasc Endovasc Surg 2006; 31(4): 386-93.

  21. Treventhan CS. Inflamación en aterosclerosis. Arch Cardiol Mex 2003; 73(Supl. 1): 141-5.

  22. Barlic J, Murphy PM. Chemoquine regulation of atherosclerosis. J Leukoc Biol 2007; 82(2): 226-36.

  23. Maiti R, Agrawal NK. Atherosclerosis in diabetes mellitus: Role of inflammation. Indian J Med Sci 2007; 61(5): 292-306.

  24. Paoletti R, Bolego C, Poli A, Cignarella A. Metabolic syndrome, inflammation and atherosclerosis. Vasc Health Risk Manag 2006; 2(2): 145-52.

  25. Flex A, Gaetani E, Papaleo P, Straface G, Proia AS, Pecorini G, et al. Proinflamatory genetic profiles in subjects with history of ischemic stroke. Stroke 2004; 35(10): 2270-5.

  26. Lalouschek W, Schillinger M, Hsieh K, Endler G, Greisenegger S, Marculescu R. et al. Polymorphisms of the inflammatory system and risk of ischemic cerebrovascular events. Clin Chem Lab Med 2006; 44(8): 918-23.

  27. Piñon C, Kaski JC. Inflamación, aterosclerosis y riesgo cardiovascular: PPAP-2, Lp-PLA-2 y Cistatina C. ¿Nuevas aportaciones o información redundante? Rev Esp Cardiol 2006; 59(2): 247-58.

  28. Coll B, Alonso Villaverde C, Joven J. Monocyte chemoattractant-1 and atherosclerosis: Is there room for a additional biomarker? Clin Chim Acta 2007; 383(1-2): 21-9.

  29. Tzoulaki I, Murray GD, Lee AJ, Rumley A, Lowe GD, Fowkes FG. Relative value of inflammatory, hemostatic, and rheological factors for incident myocardial infarction and stroke: the Edinburgh Artery Study. Circulation 2007; 115(16): 2119-27.

  30. Buyukhatipoglu H, Tyriaki O, Tahta K, Usalan C. Inflammation as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis in haemodialysis patients: the role of chlamydia and cytomegalovirus infection. Nephrology (Carlton) 2007; 12(1): 25-32.

  31. Arenillas JF, Alvarez-Sabin J, Molina CA, Chacón P, Fernández- Cardenas I, Ribó M, et al. Progression of syntomatic intracraneal large artery atherosclerosis is associated with a proinflammatory state and impaired fibrinolysis. Stroke 2008; 39(5): 1456-63.

  32. Watanabe J, Chou KJ, Liao JC, Miao Y, Meng HH, Ge H, et al. Differential association of hemoglobin with proinflammatory high density lipoproteins in atherogenic/hyperlipidemic mice- a novel biomarker of atherosclerosis. J Boil Chem 2007; 282(32): 23698-707.

  33. Sun J, Sukhova GK, Wolters PJ, Yang M, Kitamoto S, Libby P, et al. Mast cell promote atherosclerosis by releasing proinflammatory cytokines. Nat Med 2007; 13(6): 719-24.

  34. Elkind MS, Sciacca RR, Boden-Albala B, Rundek T, Paik MC, Sacco RL. Relative elevation in baseline leukocyte count predicts first cerebral infarction. Neurology 2005; 64(12): 2121-5.

  35. Koren-Morag N, Tanne D, Goldbourt U. White blood cell count and the incidence of ischemic stroke in coronary heart disease patients. Am J Med 2005; 118(9): 1004-9.

  36. Grau AJ, Boddy AW, Dukovic DA, Buggle F, Lichy C, Brandt T, et al. Leukocyte count as an independent predictor of recurrent ischemic events. Stroke 2004; 35(5): 1147-52.

  37. Swartz JE, Jacobson BF, Connor MD, Bernstein PL, Fritz VU. Erythrocyte sedimentation rate as a marker of inflammation and ongoing coagulation in stroke and ischaemic attack. S Afr Med J 2005; 95(8): 607-12.

  38. Woodward M, Lowe GD, Campbell DJ, Colman S, Rumley A, Chalmers J, et al. Associations of inflammatory and hemostatic variables with the risk of recurrent stroke. Stroke 2005; 36(10): 2143-7.

  39. Bos MJ, Schipper CM, Koudstaal PJ, Witteman JC, Hofman A, Breteler MM. High serum C-reactive protein level is not an independent predictor for stroke: the Rotterdam Study. Circulation 2006; 114(15): 1591-8.

  40. Tanne D, Benderly M, Goldbourt U, Haim M, Tenenbaum A, Fisman EZ, et al. C-reactive protein as a predictor of incident ischemic stroke among patients with preexisting cardiovascular disease. Stroke 2006; 37(7): 1720-4.

  41. Campbell DJ, Woodward M, Chalmers JP, Colman SA, Jenkins AJ, Kemp BE, et al. Soluble vascular cell adhesion molecule 1 and Nterminal pro-B-type natriuretic peptide in predicting ischemic stroke in patients with cerebrocascular disease. Arch Neurol 2006; 63(1): 60-5.

  42. Di Napoli M, Schwaninger M, Cappelli R, Ceccarelli E, Di Gianfilippo G, Donati C, et al. Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP Pooling Project members. Stroke 2005; 36(6): 1316-29.

  43. Somani R, Grant PJ, Kain K, Catto AJ, Carter AM. Complement C3 and C-reactive protein are elevated in South Asians independent of family history of stroke. Stroke 2006; 37(8): 2001-6.

  44. Magyar MT, Bereczki D, Csipo I, Gyimesi E, Csiba L, Valikovics A, et al. Elevated white blood cell count, CRP and fibrinogen levels are not associated with increased anti-endothelial and anti-oxi-LDL antibody, MCP-1, and RANTES levels in early onset occlusive carotid artery disease. Cytokine 2007; 37(1): 44-50.

  45. Braunersreuther V, Mach F, Steffens S. The specific role of chemokines in atherosclerosis. Thromb Haemost 2007; 97(5): 714-21.

  46. Afzal AR, Kicchl S, Daryani YP, Weerasinghe A, Zhang Y, Reindl M, et al. Common CCR5-del32 frameshift mutation associated with serum levels of inflammatory markers and cardiovascular disease risk in the Bruneck population. Stroke 2008; 39(7): 1972-8.

  47. Aukrust P, Yudestad A, Smith C. Ueland T, Gullestad L, Damas JK. Chemokines in cardiovascular risk prediction. Thromb Haemost 2007; 97(5): 748-54.

  48. Sardo MA, Campo S, Mandraffino G, Saitta C, Bonaiuto A, Castaldo M, et al. Tissue factor and monocyte chemoattractant protein-1 expression in hypertensive individuals with normal or increased intima- media wall thickness. Clin Chem 2008; 54(5): 814-23.

  49. Lambert MP, Sachais BS, Kowalska MA. Chemokines and thrombogenicity. Thromb Haemost 2007; 97(5): 722-9.

  50. Tone A, Shikata K, Ogawa D, Sasaki S, Nagase R, Sasaki M, et al. Changes of gene expression profiles in macrophages stimulated by angiotensin II— angiotensin II induces MCP-2 through AT1-receptor. J Renin Angiotensin Aldosterone Syst 2007 8(1): 45-50.

  51. Dinarello CA. Proinflamatory cytokines. Chest 2000; 118(2): 503-8.

  52. Cola C, Clementi E, Biondi-Zoccai G, Sangiorgi G. From carotid plaque biology to serologic markers of vulnerability to predict the risk of cerebrovascular events. Acta Chir Belg 2007; 107(2): 129-42.

  53. Trompet S, Pons D, DE Craen AJ, Slagboom P, Shepherd J, Blauw GJ, et al. Genetic variation in the interleukin-10 gene promoter and risk of coronary and cerebrovascular events: the PROSPER study. Ann NY Acad Sci 2007; 1100: 189-98.

  54. Basic KV, Simundic AM, Nikolac N, Topic E, Demarin V. Proinflammatory and anti-inflammatory cytokines in acute ischemic stroke and their relation to early neurological deficit and stroke outcome. Clin Biochem 2008; 41(16-17): 1330-4.

  55. Shakarishvili R, Beridze H. Proinflammatory reactants as determinants of stroke severity in elderly. Georgian Med News 2008; 162: 23-7.

  56. Peeters W, Hellings WE, de Kleijn DP, de VriesJP, Moll FL, Vink A, et al. Carotid atherosclerotic plaques stabilize after stroke: insights into the natural process of atherosclerotic plaque stabilization. Arterioscler Thromb Vasc Biol 2009; 29(1): 3-6.

  57. McColl BW, Rothwell NJ, Allan SM. Systemic inflammatory stimulus potentiates the acute phase and CXC chemokine response to experimental stroke and exacerbates brain damage via interleukine-1 and neutrophil-dependent mechanisms. J Neurosci 2007; 27(16): 403-12.

  58. Al-Bahrani A, Taha S, Shaath H, Bakhiet M. TNF-alpha and IL-8 in acute stroke and the modulation of these cytokines by antiplatelet agents. Curr Neurovasc Res 2007; 4(1): 31-7.

  59. Ehrensperger E, Minuk J, Durcan L, Mackey A, Wolfson C, Fontaine AM, et al. Predictive value of soluble intercellular adhesion molecule- 1 for risk of ischemic events in individuals with cerebrovacular disease. Cerebrovascular Dis 2005; 20(6): 456-62.

  60. Simundic AM, Basic V, Topic E, Demarin V, Vrkie N, Kunovic B, et al. Soluble adhesion molecules in acute ischemic stroke. Clin Invest Med 2004; 27(2): 86-92.

  61. Nuotio K, Lindsberg PJ, Carpén O, Soinne L, Lehtonen-Smeds EM, Saimanen E, et al. Adhesion molecule expresión in syntomatic and asyntomatic carotid stenosis. Neurology 2003; 60(12): 1890-9.

  62. Wang JY, Zhou DH, Li J, Zhang M, Deng J, Gao C, et al. Association of soluble intercellular adhesion molecule 1 with neurological deterioration of ischemic stroke: The Chongqing Stroke Study. Cerebrovascular Dis 2006; 21(1-2): 67-73.

  63. Hobeika MJ, Thompson RW, Muhs BE, Brooks PC, Gagne PJ, Matrix metalloproteinases in peripheral vascular disease. J Vasc Surg 2007; 45(4): 849-57.

  64. Carbone GL, Mauriello A, ChristiansenM, Oxvig C, Spagnoli LG, Schwartz RS, et al. Unstable carotid plaque : biochemical and cellular marker of vulnerability. Ital Heart J 2003; 4(Suppl. 5): 398-406.

  65. Kunz J. Matrix metalloproteinases and atherogenesis in dependence of age. Gerontology 2007; 53(2): 63-73.

  66. Verhoeven B, Hellings WE, Moll FL, de Vries JP, de Kleijn DP, de Bruin P, et al. Carotid atherosclerotic plaques in patients with transient ischemic attacks and stroke have unstable characteristics compared with plaques in asymptomatic and amaurosis fugax patients. J Vasc Surg 2005; 42(6): 1075-81.

  67. Jonhson JL, George SJ, Newby AC, Jackson CL. Divergent effects of matrix metalloproteinases 3, 7, 9 and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries. Proc Natl Acad Sci USA 2005; 102(43): 15575-80.

  68. Harrington SC, Simari RD, Conover CA. Genetic deletion of pregnancyassociated plasma protein-A is associated with resistance to atherosclerosis lesion development in apolipoprotein E-deficient mice challenged with a high-fat diet. Circ Res 2007; 100(12): 1696-702.

  69. Sangiorgi G, Mauriello A, Bonanno E, Oxvig C, Conover CA, Christiansen M, et al. Pregnancy-associated plasma protein-a is markedly expressed by monocyte-macrophage cells in vulnerable and ruptured carotid atherosclerotic plaques: a link between inflammation and cerebrovascular events. J Am Coll Cardiol 2006; 47(11): 2201-11.

  70. da Cunha V, Martin-McNulty B, Vincelette J, Choy DF, Li WW, Schroeder M, et al. Angiotensin II induces histomorphologyc features of unstable plaque in a murine model of accelerated atherosclerosis. J Vasc Surg 2006; 44(2): 364-71.

  71. Syrovátka P, Kraml P. Infection and atherosclerosis. Vnitr Lek 2007; 53(3): 286-91.

  72. Kaperonis EA, Liapis CD, Kakisis JD, Perrea D, Kostakis AG, Karayannakos PE. The association of carotid plaque inflammation and Chlamydia pneumoniae infection with cerebrovascular symptomatology. J Vasc Surg 2006; 44(6): 1198-204.

  73. Wohischlaeger J, Wimmer ML, Nägler DK, Haberl R, Weis S. Identification of Chlamydia pneumoniae in intracranial and extracranial arteries in patients with stroke and in controls: combined immunohistochemical and polymerase chain reaction analyses. Hum Pathol 2005; 36(4): 395-402.

  74. Johnston SC, Zhang H, Messina LM, Lawton MT, Dean D. Chlamydia pneumoniae burden in carotid arteries is associated with upregulation of plaque interleukin-6 and elevated C-reactive protein in serum. Arterioscler Thromb Vasc Biol 2005; 25(12): 2648-53.

  75. Gagliardi RJ, Silveira DR, Caffaro RA, dos Santos VP, Caiaffa- Filho HH. Chlamydia pneumoniae and symptomatic carotid atherosclerotic plaque: a prospective study. Arq Neuropsiquiatr 2007; 65(2B): 385-9.

  76. Ngeh J, Gupta S, Goodbourn C, Panaviotou B, McElligott G. Chlamydia pneumoniae in elderly patients with stroke (C-PEPS): a case-control study on the seroprevalence of Chlamydia pneumoniae in elderly patients with acute cerebrovascular disease. Cerebrovasc Dis 2003; 15(1-2): 11-6.

  77. Kawamoto R, Kajiwara T, Oka Y, Takagl Y. An association between an antibody against Chlamydia pneumoniae and ischemic stroke in elderly Japanese. Intern Med 2003; 42(7): 571-5.

  78. Elkind MS, Tondella ML, Feikin DR, Fields BS, Homma S, Di Tullio MR. Seropositivity to Chlamydia pneumoniae is associated with risk of first ischemic stroke. Stroke 2006; 37(3): 790-5.

  79. Johnsen SP, Overvad K, Ostergaard L, Tionneland A, Husted SE, Sorensen HT. Chlamydia pneumoniae seropositivity and risk of ischemic stroke: a nested case-control study. Eur J Epidemiol. 2005; 20(1): 59-65.

  80. Anzini A, Cassone A, Rasura M, Ciervo A, Beccia M, Di Lisi F, et al. Chlamydia pneumoniae infection in young stroke patients: a casecontrol study. Eur J Neurol 2004; 11(5): 321-7.

  81. Njamnshi AK, Blackett KN, Mbuagbaw JN, Gumedze F, Gupta S, Wiysonge CS. Chronic Chlamydia pneumoniae infection and stroke in Cameroon: a case-control study. Stroke 2006; 37(3): 796-9.

  82. Piechowski-Józwiak B, Mickielewicz A, Gaciong Z, Berent H, Kwiecinski H. Elevated levels of anti-chlamydia pneumoniae IgA and IgG antibodies in young adults with ischemic stroke. Acta Neurol Scand 2007; 116(3); 144-9.

  83. Kato A, Takita T, Maruyama Y, Hishida A. Chlamydia infection and progresión of carotid atherosclerosis in patients on regular haemodialysis. Nephrol Dial Transplant 2004; 189(10): 2539-46.

  84. Sander D, Winbeck K, Klingelhofer J, Etgen T, Conrad B. Progression of early carotid atherosclerosis is only temporarily reduced after antibiotic treatment of Chlamydia pneumoniae seropositivity. Circulation 2004; 109(8): 1010-5.

  85. Masoud SA, Arami MA, Kucheki E. Association between infection with Helicobacter pylori and cerebral noncardioembolic ischemic stroke. Neurol India 2005; 53(3): 303-6.

  86. Sawayama Y, Ariyama I, Hamada M, Otaguro S, Machi T, Taira Y, et al. Association between chronic Helicobacter pylori infection and acute ischemic stroke: Fukuoka Harasanshin Atherosclerosis Trial (FHAT). Atherosclerosis 2005; 178(2): 303-9.

  87. Park MH, Min JY, Koh SB, Kim BJ, Park MK, Park KW, et al. Helicobacter pylori infection and the CD14 C(-260)T gene polymorphism in ischemic stroke. Thromb Res 2006; 118(6): 671-7.

  88. Preusch MR, Grau AJ, Buggle F, Lichy C. Association between cerebral ischemia and cytotoxin-associated gene-A-bearing strains of Helicobacter pylori. Stroke 2004; 35(89): 1800-4.

  89. De Bastiani R, Gabrielli M, Ubaldi E, Benedetto E, Sanna G, Cottone C, et al. High prevalence of Cag-A positive H. pylori strains in ischemic stroke: a primary care multicenter study. Helicobacter 2008; 13(4): 274-7.

  90. Cremonini F, Gabrielli M, Gasbarrini G, Pola P, Gasparrini A. The relationship between chronic H. pylori infection, CagA seropositivity and stroke: meta-analysis. Atherosclerosis 2004; 173(2): 253-9.

  91. Pasceri V, Patti G, Cammarota G, Pristipino C, Richichi G, Di Sciascio G. Virulent strains of Helicobacter pylori and diseases: a meta-analysis. Am Heart J 2006; 151(6): 1215-22.

  92. Zhang S, Guo Y, Ma Y, Teng Y. Relationship between the cytotoxinassociated gene-A status of H pylori strains and cerebral infarction in European Caucasians and Chinese Han: a meta-analylis. World J Gastroenterol 2008; 14(8): 1286-92.

  93. Cojocaru IM, Cojocaru M, Iacob SA, Burcin C. Cerebral ischemic attack secondary to hepatitis C virus infection. Rom J Intern Med 2005; 43(3-4): 255-60.

  94. Gorczyca I, Stanek M, Podiasin B, Furmanek M, Pniewski J. Recurrent cerebral infarcts as the first manifestation of infection with the HIV virus. Folia Neuropathol 2005; 43(1): 45-9.

  95. Alexandri NM, Tavernarakis A, Potagas C, Molari H, Koutra H. Ischemic stroke and herpes simplex virus type-1 associated meningoencephalitis. Rev Neurol (Paris) 2004; 160(5 Pt 1): 579-8.1

  96. Mandrioli J, Portolani M, Cortelli P, Sola P. Middle cerebral artery thrombosis in course of parvovirus B19 infection in a young adult: a new risk factor for stroke? neurovirol 2004; 10(1): 71-4.

  97. Cowppli-Bony P, Oka DN, Datie A, Napon C, Kouassi EB. Tuberculosis and stroke: case report and literature review. Sante 2005; 15(3): 201-4.

  98. Ngeh J, Goodbourn C. Chlamydia pneumoniae, Mycoplasma pneumoniae and Legionella pneumophila in elderly patients with stroke (C-PEPS, M-PEPS, L-PEPS): a case-control study on the infectious burden of atypical respiratory pathogens in elderly patients with acute cerebrovascular disease. Strke 2005; 36(2): 259-65).

  99. León SFE, Mendoza E, Torres-Hillera M, Pinto N, Prada J, Silva CA, et al. Tripanosoma cruzi-associated cerebrovascular disease: a Casecontrol study in Eastern Colombia. J Neurol Sci 2004; 217(1): 61-4.

  100. Grau AJ, Becher H, Ziegler CM, Lichy C, Buggle F, Kaiser C, et al. Periodontal disease as a risk factor for ischemic stroke. Stroke 2004; 35(2): 496-501.

  101. Elter JR, Offenbacher S, Toole JF, Beck JD. Relationship of periodontal disease and edentulism to stroke/TIA. J Dent Res 2003; 82(12): 998-1001.

  102. Shirotani T, Takahara T, Wada K, Matsushita Y, Ono K. Tooth loss and the incidence of ischemic stroke. No To Shinkei 2005; 57(4): 314-9.

  103. Lee HJ, García RI, Janket SJ, Jones JA, Mascarenhas AK, Scott TE, et al. The association between cumulative periodontal disease and stroke history in older adults. J Periodontol 2006; 77(10): 1744- 54.

  104. Gálvez VR, Rodríguez-Contreras Pelayo R. Teoría de la causalidad en epidemiología. En: Piedrola Gil G (ed.). Medicina Preventiva y Salud Pública. 8a. Ed. Salvat; Barcelona: 1990.




2020     |     www.medigraphic.com